NICE agrees approval deal for ultra-rare juvenile bone disease
July 5, 2017Research and Development, Sales and Marketing Alexion, NICE, Strensiq
NICE has announced that it has decided to approve Alexion Pharma’s Strensiq (asfotase alfa) for the treatment of ultra-rare disease …
Google’s DeepMind app deal with NHS brought into question
July 5, 2017Medical Communications, Research and Development Alphabet, DeepMind, NHS, google
DeepMind’s deal with the NHS to develop an app that is able to detect possible kidney damage involved 1.6 million …
Tumour genome mapping could lead to improved outcomes, research finds
July 5, 2017Research and Development Cancer, Hi-C
A research team at the Babraham Institute in Cambridge, UK has revealed a new method to detect and monitor large-scale …
Gain insight into what your peers are doing
July 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, wave
When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …
Researchers boost existing antibiotic to tackle drug resistance
July 4, 2017Research and Development University of Lincoln, antibiotic resistance
The growing issue of antibiotic resistance is finding itself increasingly central in pharma’s priorities, though many still argue that the …
Stada CEO and CFO tumble in takeover turmoil
July 4, 2017Sales and Marketing Bain capital, Cinven, Stada
Stada, the German generic drugs manufacturer, saw its two most senior executives leave the company for ‘personal reasons’. Matthias Wiedenfels, …
Sun Pharma signs $55m manufacturing deal for investigational psoriasis drug
July 4, 2017Manufacturing and Production Samsung BioLogics, Sun Pharma
India’s biggest pharma firm has signed a $55 million long-term manufacturing deal with Korea’s Samsung BioLogics for Tildrakizumab, an investigational …
Johnson & Johnson face major lawsuit over vaginal mesh
July 4, 2017Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, vaginal mesh
Johnson & Johnson will face a lawsuit after 700 Australian women launched a class action suit over the failures of …
Top CMO pushes for routine genome screening on NHS
July 4, 2017Manufacturing and Production, Research and Development NHS, genome sequencing
England’s top Chief Medical Officer has called for routine DNA testing to become standard on the NHS in a bid …
Ministers move to clarify drug regulation Post-Brexit
July 4, 2017Manufacturing and Production, Medical Communications EMA, Jeremy Hunt, MHRA, NHS, NICE
Jeremy Hunt, Health Secretary, and Greg Clark, Business Secretary, have made a bold move to suggest that the UK will …
AstraZeneca generates $600 million from just two drug sales
July 3, 2017Manufacturing and Production, Sales and Marketing AstraZeneca, Seloken, Zomig
AstraZeneca is expected to generate almost $600 million from just two drug sales: Zoming, a migraine therapy, and Seloken, a …
Forging a path forward in neurological disorders
July 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing neurological disorders
The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an …
Big success and even bigger failure for Daiichi Sankyo’s experimental therapy
July 3, 2017Research and Development, Sales and Marketing Daiichi Sankyo, mirogabalin
Daiichi Sankyo has been hit with mixed news this week regarding its experimental therapy mirogabalin. The drug posted trial success …
GSK signs $43 million AI-based drug discovery deal with Exscientia
July 3, 2017Research and Development, Sales and Marketing AstraZeneca, Exscientia, GSK
With AI partnerships becoming increasingly common in the life sciences industry, it has emerged that GSK is to partner up …
New Pfizer EU approval offers first treatment option for leukaemia subtype
July 3, 2017Sales and Marketing AstraZeneca, Besponsa, EU, European Commission
Pfizer has revealed that its drug Besponsa (inotuzumab ozogamicin) has received approval from the European Commission as a monotherapy for …
Free Webinar: How will quality management change by 2025?
July 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Webinar, veeva
Following on from the success of our previous free webinar sessions, Pharmafocus is partnering
NICE recommends AstraZeneca lung treatment
July 3, 2017Sales and Marketing AstraZeneca, Daxas, NICE
AstraZeneca’s Daxas (roflumilast) has received recommendation from NICE for the treatment of chronic obstructive pulmonary disease (COPD) it has emerged, …
Pricing Consultant Job Profile and Description
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI
Pricing Consultant Job Profile and Description About Global Pricing Innovations (GPI)
Head of Product Innovation Job Profile and Description
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI
Head of Product Innovation Job Profile and Description About Global Pricing Innovations (GPI)
Development Manager Job Profile and Description
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI
Development Manager Job Profile and DescriptionGPI is a global pricing consultancy launching products, services and offerings that make a measurable …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
